| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 7 555-561, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
RP Evarts, Z Hu, K Fujio, ER Marsden and SS Thorgeirsson
Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
We have demonstrated previously a pronounced increase in the expression of hepatocyte growth factor (HGF) (Z. Hu, R. P. Evarts, K. Fujio, E. R. Marsden, and S. S. Thorgeirsson, Am. J. Pathol., 142: 1823-1830, 1993), transforming growth factor alpha (TGF-alpha) (R. P. Evarts, H. Nakatsukasa, E. R. Marsden, Z. Hu, and S. S. Thorgeirsson, Mol. Carcinog., 5: 25-31, 1992), and acidic fibroblast growth factor (aFGF) (E. R. Marsden, Z. Hu, K. Fujio, H. Nakatsukasa, S. S. Thorgeirsson, and R. P. Evarts, Lab. Invest., 67: 427-433, 1992) that coincided with the proliferation and differentiation of putative hepatic stem cells and perisinusoidal stellate (Ito) cells. Here, we examine the earliest stages of stem cell activation in rat liver using an experimental model involving treatment with acetylaminofluorene and partial hepatectomy (R. P. Evarts, P. Nagy, E. Marsden, and S. S. Thorgeirsson, Carcinogenesis (Lond.), 8: 1737-1740, 1987). Histochemical identification of stem cell progeny and Ito cells was accomplished by OV6 and desmin antibodies, respectively. Expression of the 2.1-kilobase alpha-fetoprotein transcripts and the concomitant DNA synthesis ([3H]thymidine label) were used as indicators for the activation of the stem cell compartment. Expression of HGF, TGF-alpha, and aFGF was analyzed at the time of partial hepatectomy and 4, 12, 24, 48, 72, and 92 h after the operation. [3H]-Thymidine-labeled OV6- and desmin-positive cells were present in the portal space and in the Glisson capsule 4 h after partial hepatectomy.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
C. L. Stoick-Cooper, R. T. Moon, and G. Weidinger Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine Genes & Dev., June 1, 2007; 21(11): 1292 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Li, J. Su, Y.-C. Yao, X.-R. Tao, Y.-B. Yan, H.-Y. Yu, X.-M. Wang, J.-X. Li, Y.-J. Yang, J. T.Y. Lau, et al. Isolation and Characterization of Bipotent Liver Progenitor Cells from Adult Mouse Stem Cells, February 1, 2006; 24(2): 322 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Mullin, M. S. Metcalfe, and G. J. Maddern Artificial Liver Support: Potential to Retard Regeneration? Arch Surg, June 1, 2004; 139(6): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Jensen, E. I. Jauho, E. Santoni-Rugiu, U. Holmskov, B. Teisner, N. Tygstrup, and H. C. Bisgaard Transit-Amplifying Ductular (Oval) Cells and Their Hepatocytic Progeny Are Characterized by a Novel and Distinctive Expression of Delta-Like Protein/Preadipocyte Factor 1/Fetal Antigen 1 Am. J. Pathol., April 1, 2004; 164(4): 1347 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
K N Lowes, E J Croager, L J Abraham, J K Olynyk, and G C T Yeoh Upregulation of lymphotoxin {beta} expression in liver progenitor (oval) cells in chronic hepatitis C Gut, September 1, 2003; 52(9): 1327 - 1332. [Abstract] [Full Text] |
||||
![]() |
K. M. Braun, A. W. Thompson, and E. P. Sandgren Hepatic Microenvironment Affects Oval Cell Localization in Albumin-Urokinase-Type Plasminogen Activator Transgenic Mice Am. J. Pathol., January 1, 2003; 162(1): 195 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, D. S.R. Sarma, and M. C. Archer Inheritance of Resistance to Promotion of Preneoplastic Liver Lesions in Copenhagen Rats Experimental Biology and Medicine, October 1, 2001; 226(9): 831 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, D. S.R. Sarma, and M. C. Archer Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats Carcinogenesis, July 1, 1999; 20(7): 1169 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Spagnoli, L. Amicone, M. Tripodi, and M. C. Weiss Identification of a Bipotential Precursor Cell in Hepatic Cell Lines Derived from Transgenic Mice Expressing Cyto-Met in the Liver J. Cell Biol., November 16, 1998; 143(4): 1101 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Novikoff and A. Yam Stem Cells and Rat Liver Carcinogenesis: Contributions of Confocal and Electron Microscopy J. Histochem. Cytochem., May 1, 1998; 46(5): 613 - 626. [Abstract] [Full Text] |
||||
![]() |
R. Isfort, D. Cody, S. Stuard, C. Randall, C Miller, G. Ridder, C. Doersen, W. Richards, B. Yoder, J. Wilkinson, et al. The combination of epidermal growth factor and transforming growth factor-beta induces novel phenotypic changes in mouse liver stem cell lines J. Cell Sci., January 12, 1997; 110(24): 3117 - 3129. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |